OTC Pharmaceuticals - France

  • France
  • In France, the revenue in the OTC Pharmaceuticals market is projected to reach US$4,403.00m in 2024.
  • It is expected that the market will experience an annual growth rate of 2.75% (CAGR 2024-2029).
  • Among the various markets, the largest market is Other OTC Pharmaceuticals, with a market volume of US$1,465.00m in 2024.
  • When compared globally, the in the United States generates the highest revenue, amounting to US$41,240.00m in 2024.
  • Taking into account the population figures, the per person revenue in France is estimated to be US$67.86 in 2024.
  • Regarding the sales distribution channels, it is anticipated that online sales will contribute 20.05% of the total revenue in the OTC Pharmaceuticals market by 2024.
  • France's OTC Pharmaceuticals market is witnessing a growing demand for natural and herbal remedies as consumers prioritize holistic health and wellness.

Key regions: United States, China, Germany, Japan, Europe

Region comparison

Analyst Opinion

The OTC Pharmaceuticals market in France is experiencing steady growth due to changing customer preferences and market trends. Customer preferences in the OTC Pharmaceuticals market in France are shifting towards self-medication and convenience. Consumers are increasingly seeking over-the-counter products that allow them to treat common ailments without the need for a doctor's prescription. This preference for self-medication is driven by factors such as convenience, cost-effectiveness, and the desire for quick relief from minor health issues. Additionally, the availability of a wide range of OTC products in pharmacies and supermarkets makes it easier for consumers to access and purchase these medications.Trends in the OTC Pharmaceuticals market in France are also contributing to its development. One notable trend is the growing demand for natural and herbal remedies. Consumers are becoming more conscious of the ingredients in the products they use and are seeking alternatives to traditional pharmaceuticals. This trend is fueled by a desire for more holistic and sustainable healthcare options. As a result, manufacturers are introducing more natural and herbal OTC products to cater to this demand.Another trend in the market is the increasing use of online platforms for purchasing OTC Pharmaceuticals. E-commerce has gained significant popularity in recent years, and consumers are now turning to online retailers to buy their healthcare products. The convenience of online shopping, coupled with the availability of a wide range of products and competitive pricing, has made it an attractive option for consumers. This trend has led to the growth of online pharmacies and the expansion of e-commerce platforms in the OTC Pharmaceuticals market in France.Local special circumstances in France also contribute to the development of the OTC Pharmaceuticals market. The country has a well-established healthcare system, with a strong emphasis on preventive care and self-medication. The French government encourages self-care and promotes the use of OTC medications for minor health issues. This supportive regulatory environment has created a favorable market for OTC Pharmaceuticals in France.Underlying macroeconomic factors also play a role in the growth of the OTC Pharmaceuticals market in France. The country has a stable economy and a high standard of living, which allows consumers to afford OTC medications. Additionally, the aging population in France is driving the demand for OTC Pharmaceuticals, as older individuals are more likely to experience health issues that can be treated with these products. The increasing prevalence of chronic diseases, such as diabetes and cardiovascular conditions, also contributes to the demand for OTC medications.In conclusion, the OTC Pharmaceuticals market in France is developing due to changing customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. The shift towards self-medication, the demand for natural and herbal remedies, the rise of online platforms, and the supportive regulatory environment are all contributing to the growth of the market.


Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.


In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.


  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait


Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)